http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105496979-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105496979-B |
| titleOfInvention | A kind of Rasagiline tablet |
| abstract | The invention discloses a kind of Rasagiline, which includes：Contain by weight percentage：1%~3% rasagiline mesilate, 1.5%~3% hydroxypropyl methylcellulose, 0.3%~3% EDTA 2Na, 50%~75% microcrystalline cellulose, the tablet is prepared using wet granulation, including main ingredient and EDTA 2Na are dissolved in the hydroxypropyl methylcellulose solution of part, the suspension that the solution is formed with portions microcrystalline cellulose is stirred, mixed again with remaining microcrystalline cellulose and remaining hydroxypropyl methylcellulose solution carry out wet granulation, tabletting and obtain.Prescription of the present invention is simple, each process is easily operated, and production cost is low, is suitble to industrialized production；And obtained product has good long-time stability. |
| priorityDate | 2015-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.